Hobart Private Capital, LLC Sanofi Transaction History

Hobart Private Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Mar 11, 2024	SELL	$40.83 - $45.43 $423,080 - $470,745	-10,362 Closed	0 $0
Q4 2018 Mar 11, 2024	BUY	$41.48 - $45.59 $429,815 - $472,403	10,362 New	10,362 $450 Million
Q3 2018 Mar 11, 2024	SELL	$40.0 - $44.84 $617,560 - $692,284	-15,439 Closed	0 $0
Q2 2018 Mar 11, 2024	SELL	$37.63 - $41.22 $47,601 - $52,143	-1,265 Reduced 7.57%	15,439 $618 Million
Q1 2018 Mar 11, 2024	BUY	$38.98 - $45.76 $651,121 - $764,375	16,704 New	16,704 $669 Million
Q4 2017 Mar 11, 2024	BUY	$42.86 - $50.61 $719,962 - $850,146	16,798	16,798 $722 Million

795

252M

2.6M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $139B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.